Dermatomyositis

Last revised by Rohit Sharma on 4 Jul 2024

Dermatomyositis is an idiopathic inflammatory myopathy, presumably autoimmune in etiology, which carries an increased risk of malignancy. It is considered a distinct condition to anti-synthetase syndrome.

There is a recognized female predilection. It has a bimodal age of presentation depending on the variant:

The classic presentation is that of a myalgic symmetrical proximal myopathy with associated dermatological changes which includes a dusky-red rash over the face (e.g. heliotrope rash), arms, hands (e.g. Gottron papules), legs (e.g. holster sign) and other features (e.g. V sign and shawl sign) 10. Dysphagia, myalgia, fever and weight loss are other features 7.

There is a sixfold increased risk of malignancy in dermatomyositis (cf. twofold in polymyositis) 8. Multiple risk factors for the development of malignancy have been identified 8:

There is cell-mediated injury targeted at striated muscle with resultant atrophy, edema, coagulation necrosis, fibrosis and calcification. Additionally, it is thought that enhanced type 1 interferon signaling plays a critical role in its pathogenesis 12.

  • elevated muscle enzymes (e.g. CK)

  • elevated myositis-specific antibodies

    • anti-Mi2

    • anti-MDA5

    • anti-TIF1γ

    • anti-NXP2

    • anti-SAE

  • typically shows dystrophic calcification in muscles and soft tissues (calcinosis universalis)

    • sheet-like although at least four patterns have been described with childhood dermatomyositis 4

    • classically seen affecting the thigh regions

  • chest radiograph may show diaphragmatic elevation

  • acro-osteolysis

  • may show disordered peristalsis involving the upper esophagus i.e. the portion supplied by skeletal muscle

  • T2: generally hyperintense signal throughout the affected muscles; calcific areas may be low signal; peri-muscular edema may additionally appear as high signal; signal intensity may return to normal after treatment 4

Management of myositis is primarily with immunosuppression. Options include corticosteroids and steroid-sparing agents (e.g. azathioprine, mycophenolate, methotrexate, etc.) 9.

General imaging differential considerations include:

MRI T2-weighted sequences are useful to guide muscle biopsy: 

  • areas of edema related to the active inflammatory process

  • non-specific end-stage fatty atrophic muscle should be avoided 

Further imaging in the form of a contrast-enhanced CT of the chest, abdomen and pelvis may be undertaken to exclude an associated primary malignancy.

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.